 |
|
Gene mutation may influence age at onset of Parkinson's disease
June 13, 2006The number of mutations in a gene previously found to be associated with early-onset Parkinson's disease may influence the age at which the condition develops; even individuals who carry just one mutated copy may be more susceptible to Parkinson's disease, according to a report in the June issue of Archives of Neurology, one of the JAMA/Archives journals.
Parkinson's disease affects about 1 percent of individuals age 60 years or older and 4 to 5 percent of those age 85 years or older, according to background information in the article. The neurodegenerative disorder is characterized by tremors, rigid movements, difficulty walking and a mask-like facial appearance. Though much about the development of Parkinson's disease remains unknown, family history has been found to significantly increase risk. Researchers have located several genes that may be implicated, including the parkin gene. About 50 percent of individuals with "juvenile" parkinsonism (in which features of Parkinson's disease develop before age 21 years) and 10 to 25 percent of those with early-onset (before age 50) Parkinson's disease have mutated parkin genes.
Mei Sun, M.D., Ph.D., Massachusetts General Hospital and Harvard Medical School, Boston, and colleagues studied 183 families in which two or more members had Parkinson's disease. The families also met one of two other criteria: either one individual in the family developed Parkinson's disease before age 54 years, or two affected siblings had identical versions of the parkin gene. Because siblings inherit one chromosome from their mother and one chromosome from their father, they can share either zero, one or two versions of each gene. At least one member of each family underwent comprehensive genetic screening to determine the number and nature of any mutations to the parkin gene.
Twenty-three (12.6 percent) of the families screened contained at least one member with a mutated parkin gene. Among those families, 10 (43 percent) had at least one member with two different mutations; three (13 percent) had at least one member with two copies of the same mutation; and 10 (43 percent) had at least one member with one mutated parkin gene and one normal parkin gene. Individuals with one mutated gene and one normal gene are known as heterozygotes; researchers had not previously determined whether heterozygotes were at increased risk for Parkinson's disease. Patients with parkin mutations developed Parkinson's disease at an average age of 42.9 years. Among the families who were selected because two siblings shared the same version of the parkin gene, heterozygotes developed Parkinson's disease an average of 11.7 years earlier than those with no mutations, and those with two or more mutations developed the condition 13.2 years earlier than heterozygotes.
"In conclusion, parkin mutations are not rare in this selected subset of familial Parkinson's disease samples (12.6 percent)," the authors write. "Single parkin mutations may increase susceptibility to the disease and decrease the onset age of Parkinson's disease (mean onset age, 49.6 years)." The fact that even heterozygotes developed Parkinson's disease at an earlier age than those with two normal copies indicates that the gene's effect may be stronger than previously recognized, and that screening for mutations in the gene may help identify those at risk of developing the condition.
(Arch Neurol. 2006;63:826-832. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This study was supported by the Bumpus Foundation and grants from the U.S. Public Health Service. The DNA samples contributed by the Parkinson Institute, Istituti Clinici di Perfezionamento, were from the Human Genetic Bank of Patients Affected by Parkinson Disease and Parkinsonisms, supported by a grant from the Italian Telethon Foundation.
Editorial: Genetic Studies Help Explain Parkinson's Disease Development
Understanding how mutations in parkin and other genes contribute to Parkinson's disease offers valuable clues to the still-mysterious pathways of its development, write Roger N. Rosenberg, M.D., editor, Archives of Neurology, and Uwe Beffert, Ph.D., both of University of Texas, Southwestern Medical Center, Dallas, in an accompanying editorial.
The editorialists note that if the results of this study are confirmed, they write, they "will require a reexamination of the genetic data associated with Parkinson's disease to take into account the possibility that heterozygous mutations in autosomal recessive genes such as parkin and PINK1 affect the susceptibility and age of onset of Parkinson's disease. These findings are provocative and add a new genetic dimension to the pathogenesis of Parkinson's disease."
JAMA and Archives Journals
Twenty-three (12.6 percent) of the families screened contained at least one member with a mutated parkin gene. Among those families, 10 (43 percent) had at least one member with two different mutations; three (13 percent) had at least one member with two copies of the same mutation; and 10 (43 percent) had at least one member with one mutated parkin gene and one normal parkin gene. Individuals with one mutated gene and one normal gene are known as heterozygotes; researchers had not previously determined whether heterozygotes were at increased risk for Parkinson's disease. Patients with parkin mutations developed Parkinson's disease at an average age of 42.9 years. Among the families who were selected because two siblings shared the same version of the parkin gene, heterozygotes developed Parkinson's disease an average of 11.7 years earlier than those with no mutations, and those with two or more mutations developed the condition 13.2 years earlier than heterozygotes.
"In conclusion, parkin mutations are not rare in this selected subset of familial Parkinson's disease samples (12.6 percent)," the authors write. "Single parkin mutations may increase susceptibility to the disease and decrease the onset age of Parkinson's disease (mean onset age, 49.6 years)." The fact that even heterozygotes developed Parkinson's disease at an earlier age than those with two normal copies indicates that the gene's effect may be stronger than previously recognized, and that screening for mutations in the gene may help identify those at risk of developing the condition.
(Arch Neurol. 2006;63:826-832. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: This study was supported by the Bumpus Foundation and grants from the U.S. Public Health Service. The DNA samples contributed by the Parkinson Institute, Istituti Clinici di Perfezionamento, were from the Human Genetic Bank of Patients Affected by Parkinson Disease and Parkinsonisms, supported by a grant from the Italian Telethon Foundation.
Editorial: Genetic Studies Help Explain Parkinson's Disease Development
Understanding how mutations in parkin and other genes contribute to Parkinson's disease offers valuable clues to the still-mysterious pathways of its development, write Roger N. Rosenberg, M.D., editor, Archives of Neurology, and Uwe Beffert, Ph.D., both of University of Texas, Southwestern Medical Center, Dallas, in an accompanying editorial.
The editorialists note that if the results of this study are confirmed, they write, they "will require a reexamination of the genetic data associated with Parkinson's disease to take into account the possibility that heterozygous mutations in autosomal recessive genes such as parkin and PINK1 affect the susceptibility and age of onset of Parkinson's disease. These findings are provocative and add a new genetic dimension to the pathogenesis of Parkinson's disease."
JAMA and Archives Journals
Parkinsons Disease Current Events and Parkinsons Disease News RSSHigher occurrence of Parkinson's linked to low LDL cholesterol
People with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels, according to University of North Carolina at Chapel Hill researchers.
Synchronous neuronal firing may underlie Parkinson's disease
In a finding that contradicts current theories behind Parkinson's disease, neuroscientists at Duke University Medical Center have discovered in mice that critical nerve cells fire all at the same time and thus overwhelm the brain's ability to control the body's movements.
Dopamine imbalances cause sleep disorders in animal models of Parkinson's disease and schizophrenia
Neuroscientists at Duke University Medical Center working with genetically engineered mice have found that the brain chemical dopamine plays a critical role in regulating sleep and brain activity associated with dreaming.
Researchers announce results of study on genetic variation in Parkinson's disease
Researchers at the National Institutes of Health (NIH) have completed one of the first large-scale studies of the role of common genetic variation in Parkinson's disease (PD).
Laser probe of a brain pigment's anatomy may offer insight into Parkinson's disease
In a finding that may offer clues about Parkinson's disease, a team led by Duke University researchers used a sophisticated laser system to gain evidence that a dark brown pigment that accumulates in people's brains consists of layers of two other pigments commonly found in hair.
Two copies of G2019S Parkinson's gene mutation doesn't lead to more severe disease
A group of Parkinson's disease researchers concluded there are no observable differences between those who have two copies of the most common mutation of the recently discovered LRRK2 gene and those who have only one copy.
Government cash injection for University spin-out company's stem cell research
A spin-out company from the University of Nottingham has been awarded around £250,000 of Government funding to develop innovative stem cell therapies that could one day provide new treatments for patients suffering from illnesses including Parkinson's disease and stroke.
Two minutes of magnetic stimulation can change your brain for an hour
A couple of minutes is all it takes to 'knock out' bits of your brain for an hour, according to a new study by a University College London (UCL) team. The team have been working on ways to improve a method known as transcranial magnetic stimulation (TMS) and are now using their adapted version of TMS to investigate possible treatments for stroke patients or those with Parkinson's disease.
Gene therapy shows promise in model of Parkinson's disease
Scientists at the Ecole Polytechnique Federale de Lausanne (EPFL) in Lausanne, Switzerland, have conducted novel experiments that might one day lead to gene therapy treatment options for patients with Parkinson's disease. In research published this week in the Proceedings of the National Academy of Sciences, the research team, led by EPFL President Patrick Aebischer, found that viral delivery of a gene associated with Parkinson's disease protected neurons from degeneration. Parkinson's disease is a progressive, degenerative neurological disorder in which dopamine-producing neurons in the part of the brain responsible for coordinating muscle movement die or become so damaged that they are no
Limitations of Current Evaluation Techniques for the Cost-Effectiveness of Treatments for Parkinson's Disease
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Pharmaceutical and surgical therapies for PD are available and can alleviate the symptoms and complications. Unfortunately, despite these therapies, the disease relentlessly progresses. A new study in the journal Value in Health presents a detailed overview of the current decision-analytic models used to evaluate the cost-effectiveness of therapeutic options in Parkinson's disease.
More Parkinsons Disease Current Events and Parkinsons Disease News Articles
 | Parkinson's Disease: A Complete Guide for Patients and Families (A Johns Hopkins Press Health Book) by William J. Weiner, Lisa M. Shulman, Anthony E. Lang Recent innovations, including deep brain stimulation and new medications, have significantly improved the lives of people with Parkinson's disease. Nevertheless, medical, emotional, and physical challenges remain. The second edition of this accessible and comprehensive guide provides crucial information for managing this complex condition, including details on the use of medications, diet,... |
 | Delay the Disease -Exercise and Parkinson's Disease by David Zid David Zid, an ACE, APG certified trainer, has collaborated with orthopedic surgeon, Thomas H. Mallory, M.D., who is afflicted with Parkinson's disease, in the development of a Parkinson's specific fitness program designed to proactively minimize tremors and improve flexibility, stability, balance and strength. Delay the Disease contains colorful photographs of Zid demonstrating each move, as well... |
 | Parkinson's Disease: 300 Tips for Making Life Easier by Shelley Peterman Schwarz Being diagnosed with Parkinson's disease can be distressing, and adjusting to the effects of the disease is often difficult. This indispensable resource for patients, family, friends, and caregivers helps patients rise above PD’s challenges by working smarter, maintaining a positive outlook, and conserving time and energy. Organized by subject, the book covers a wide range of topics, including... |
 | Living Well with Parkinson's Disease: What Your Doctor Doesn't Tell You....That You Need to Know (Living Well) by Gretchen Garie, Michael J. Church A complete guide to Parkinson's from two people with the disease who cofounded a national support and advocacy organization. In Living Well with Parkinson's Disease, Gretchen Garie and Michael J. Church, a couple who both have Parkinson's and live daily with the effects of the disease, thoroughly discuss diagnosis, treatment options, and the emotional consequences of this difficult illness.... |
 | Parkinson's Disease For Dummies (For Dummies (Health & Fitness)) by Michele Tagliati, Gary Guten, Jo Horne If you or someone you love has been diagnosed with Parkinson’s Disease you’re probably wrestling with fear, despair, and countless questions about the future. It’s brighter than you think. In Parkinson’s Disease for Dummies, you’ll discover how to keep a positive attitude and lead an active, productive life as this user-friendly, guide pilots you through the important steps toward... |
 | What Your Doctor May Not Tell You About Parkinson's Disease: A Holistic Program for Optimal Wellness by Jill Marjama-Lyons, Mary J. Shomon There are over one million people in the U.S. living with Parkinson's disease, a debilitating neurological disorder. Patients can now choose from a variety of increasingly effective treatments, including new drugs, revolutionary surgical techniques, and cutting-edge alternative treatments such as intravenous glutathione therapy. The book covers not only the pros and cons of prescription drug and... |
 | The Parkinson's Disease Treatment Book: Partnering with Your Doctor to Get the Most from Your Medications by J. Eric Ahlskog Nearly one million Americans, including Michael J. Fox and Muhammad Ali, suffer from Parkinson's Disease. Now, a leader in the fight against Parkinson's, Dr. J. Eric Ahlskog of the Mayo Clinic, has written the definitive guide for patients and their families. Dr. Ahlskog offers a crystal-clear, nuts-and-bolts approach to the treatment of PD, distilled from over twenty years of experience as... |
 | The Comfort of Home for Parkinson Disease: A Guide for Caregivers (Comfort of Home, The) by Maria M. Meyer, Paula Derr This comprehensive guide to the day-to-day issues confronted by Parkinson disease patients and their caregivers covers every caregiving stage.It's all here in an illustrated, easy-to-read format, including the decision to provide home care, preparing the home, assisting with daily activities, financial management, and strategies for avoiding caregiver burnout. This guide also includes... |
 | Parkinson's Disease & the Art of Moving by John Argue Faced with an incurable and often debilitating illness, Parkinson's patients must relearn how to sit up in a chair, speak clearly, keep their balance while walking, and stand from a sitting position. Over 100 photographs illustrate exercises derived from yoga and t'ai chi techniques; and theater movement skills show readers how to cope as gracefully as possible with the loss of coordination that... |
 | The First Year---Parkinson's Disease: An Essential Guide for the Newly Diagnosed by Jackie Hunt Christensen Parkinson's disease—a chronic disorder that causes a progressive loss of nerve cell function in the part of the brain that controls muscle movement—is an incurable neurological condition with debilitating symptoms. Over 1.5 million Americans are affected, and the numbers continue to grow. From the first moment of her Parkinson's diagnosis, author Jackie Christensen took charge and educated... |
| © 2008 BrightSurf.com |